Viking Therapeutics, Inc.
(VKTX - NASDAQ)
33,02 USD
📋 Profilo Aziendale

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

|